

(© Leo – stock.adobe.com)
In a nutshell
- Brain aging follows a nonlinear path with a critical transition point starting around age 44, driven primarily by increasing insulin resistance in brain cells.
- Ketones can temporarily reverse brain network destabilization, with effects strongest during ages 40-60 – a “critical window” when neurons are stressed but still viable.
- Prevention may be most effective decades before symptoms appear, suggesting midlife metabolic interventions could significantly impact long-term brain health.
STONY BROOK, N.Y. — Brain aging follows a surprising trajectory with a potentially game-changing discovery: there appears to be a crucial “window” in middle age when interventions targeting metabolism could significantly slow or stabilize signs of brain aging. This revelation comes from new research where scientists integrated multiple studies with nearly 20,000 participants to map brain aging patterns and test metabolic interventions.
The Unexpected Curve of Brain Aging
Most of us expect brain aging to proceed gradually throughout our lives, but this new research shows it actually follows a nonlinear path with distinct transition points. Like a road with unexpected twists rather than a gentle slope, our brains maintain relatively steady function until around age 43, when detectable changes in neural network stability begin to accelerate. This destabilization continues until around age 67, when the rate of change slows again.
The research team, led by scientists at the State University of New York at Stony Brook and Massachusetts General Hospital, discovered that the earliest transition point in brain aging coincides with increasing insulin resistance. This metabolic change appears to precede vascular and inflammatory changes, pointing to it as a driving mechanism behind brain aging rather than just a consequence.
“Understanding exactly when and how brain aging accelerates gives us strategic timepoints for intervention,” says lead author Lilianne R. Mujica-Parodi, Director of the Laboratory for Computational Neurodiagnostics (LCNeuro) and Professor of Biomedical Engineering at Stony Brook University.
“We’ve identified a critical midlife window where the brain begins to experience declining access to energy but before irreversible damage occurs, essentially the ‘bend’ before the ‘break.’ During midlife, neurons are metabolically stressed due to insufficient fuel; they’re struggling, but they’re still viable,” she explains. “Therefore, providing an alternative fuel during this critical window can help restore function. However, by later ages, neurons’ prolonged starvation may have triggered a cascade of other physiological effects that make intervention less effective.”
How Ketones Support Brain Networks
The study, published in PNAS, revealed that brain networks begin to destabilize around age 44, with the degeneration accelerating most rapidly at age 67 and plateauing by age 90. When researchers administered ketone supplements to participants, they observed significant stabilization of brain network activity.
Ketones are alternative fuel molecules that the body produces during fasting or low-carbohydrate diets. Unlike glucose (sugar), which requires insulin to enter many cells, ketones can provide energy to neurons without insulin. This alternative pathway becomes crucial when insulin resistance develops.
The effect of ketones was strongest during the “critical window” between ages 40-60, coinciding with the period of most rapid network destabilization. In participants aged 40-59, the stabilizing effect was nearly 85% larger than in younger adults. However, in older adults (60-79), the benefit dropped dramatically, suggesting that by the time we reach our late 60s and 70s, some of the metabolic damage may have become less reversible.
“This represents a paradigm shift in how we think about brain aging prevention,” notes Botond Antal, PhD, Postdoctoral Associate in Biomedical Engineering at Stony Brook and first author. “Rather than waiting for cognitive symptoms, which may not appear until substantial damage has occurred, we can potentially identify people at risk through neurometabolic markers and intervene during this critical window.”
The Genetic Links: Finding the Key Players
The research team found that specific genes and transporters play crucial roles in brain aging. Three genes in particular showed significant correlations with aging patterns:
- GLUT4 – the insulin-dependent glucose transporter
- MCT2 – the neuronal ketone transporter
- APOE – a lipid transport protein associated with Alzheimer’s risk
MCT2 emerged as a potential protective factor. This transporter helps brain cells take up ketones, which may help protect against the effects of declining insulin sensitivity.
Prevention Rather Than Treatment
From a public health standpoint, these findings could transform how we approach brain aging. Rather than waiting until cognitive symptoms appear in our 60s or 70s, the optimal time for intervention may be decades earlier—in our 40s and 50s—when metabolic interventions could have their greatest impact.
Early identification of increasing insulin resistance in the brain, coupled with targeted metabolic interventions, might substantially delay cognitive aging for millions of people. With dementia cases projected to triple by 2050, these insights offer new hope for preventive strategies that could maintain cognitive health well into later life.
The ‘Bend Before Break’ Principle
The researchers compared the brain to a system that “bends before it breaks.” During midlife, regulatory mechanisms maintaining optimal brain energy supply start to become strained but haven’t yet failed completely. This period represents a critical opportunity for intervention.
By the time most people reach their 60s and 70s, chronically stressed neurons may have undergone more permanent changes that can’t be easily stabilized simply by providing alternative fuel. This timing aligns with when cognitive decline often accelerates and clinical symptoms of conditions like mild cognitive impairment begin to appear.
Using magnetic resonance spectroscopy, the researchers confirmed that the diminished effect in older adults wasn’t due to reduced ketone uptake into the brain but rather reflected changes in how efficiently aging neurons could utilize this alternative fuel.
Comprehensive Approach to Brain Aging
The study’s strength lies in its multi-faceted approach. The researchers combined large-scale population data, genetic analyses, and interventional testing to build a comprehensive picture of brain aging. This integrated approach allowed them to distinguish between potential driving mechanisms and downstream effects—a critical distinction when trying to identify the most effective points for intervention.
While the study used controlled ketone supplementation in a laboratory setting, the findings align with previous work showing benefits of dietary approaches that promote ketone production, such as intermittent fasting or low-carbohydrate diets.
Like a house that shows early signs of structural weakness, the aging brain may benefit most from timely reinforcement before small issues cascade into larger problems. The identification of this midlife critical window provides not just scientific insight but practical guidance for when metabolic interventions might yield their greatest benefits for long-term brain health.
Paper Summary
Methodology
The research team employed a comprehensive approach to investigate brain aging. First, they analyzed four large neuroimaging datasets totaling 19,300 participants, measuring how consistently brain regions maintain their connections over time. They discovered this network instability followed an S-shaped curve across the lifespan. After identifying this pattern, they examined which physiological changes coincided with the transition points, finding that increases in HbA1c (a marker of insulin resistance) aligned with the onset of network destabilization in the mid-40s. They then compared patterns of brain aging with gene expression maps and conducted an interventional study with 101 participants across three age groups, who received either ketone supplements or glucose while undergoing brain scans.
Results
The study revealed brain network destabilization following an S-shaped curve with key transition points at approximately age 44 (onset), 67 (most rapid change), and 90 (plateau). Only three genes showed significant correlations with aging patterns: GLUT4, MCT2, and APOE. The interventional study demonstrated that ketone supplementation significantly stabilized brain networks, with maximum benefit during midlife (40-59 years) and diminished effects in older adults (60-79 years). Glucose supplementation showed no significant stabilizing effects in any age group. Importantly, the diminished effect in older adults wasn’t due to reduced ketone uptake into the brain but reflected changes in how efficiently aging neurons could utilize this alternative fuel.
Limitations
While comprehensive, this study has several limitations. The cross-sectional design observed different individuals rather than following the same people over time. The intervention used acute administration of ketones rather than long-term supplementation, and focused on brain network measures rather than cognitive performance. Additionally, the gene expression data came from a limited sample which may not fully capture age-related changes, and the study acknowledges that neuronal insulin resistance itself may stem from earlier changes in mitochondrial function not fully explored in this research.
Discussion and Takeaways
This research identifies a critical midlife window (ages 40-60) when metabolic interventions may have their greatest impact on brain aging. It highlights neuronal insulin resistance as a primary driver of early brain aging and establishes ketones as effective in temporarily reversing brain network destabilization, particularly during midlife. The identification of specific transporters like MCT2 provides potential targets for future interventions. Unlike current approaches that typically target symptoms after they appear, this research suggests metabolic interventions might be most effective when started in one’s 40s, well before cognitive symptoms develop.
Funding and Disclosures
The research was funded by the W.M. Keck Foundation and the NSF Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. Researcher Kieran Clarke disclosed that the intellectual property covering the ketone ester is owned by the University of Oxford and the NIH, licensed to TdeltaS Global Inc. As an inventor, Clarke receives royalty shares and is a director of TdeltaS Ltd., a company developing ketone-based products.
Publication Information
The paper, “Brain aging shows nonlinear transitions, suggesting a midlife ‘critical window’ for metabolic intervention,” was published in PNAS on March 3, 2025 (Volume 122, Number 10). Lead authors were Botond B. Antal, Helena van Nieuwenhuizen, and Anthony G. Chesebro, with senior authors Ken A. Dill and Lilianne R. Mujica-Parodi. The collaborative work involved scientists from Stony Brook University, Massachusetts General Hospital, Mayo Clinic, Oxford University, and Memorial Sloan Kettering.